Unknown

Dataset Information

0

Differential effects of denileukin diftitox IL-2 immunotoxin on NK and regulatory T cells in nonhuman primates.


ABSTRACT: Denileukin diftitox (DD), a fusion protein comprising IL-2 and diphtheria toxin, was initially expected to enhance antitumor immunity by selectively eliminating regulatory T cells (Tregs) displaying the high-affinity IL-2R (?-?-? trimers). Although DD was shown to deplete some Tregs in primates, its effects on NK cells (CD16(+)CD8(+)NKG2A(+)CD3(-)), which constitutively express the intermediate-affinity IL-2R (?-? dimers) and play a critical role in antitumor immunity, are still unknown. To address this question, cynomolgus monkeys were injected i.v. with two doses of DD (8 or 18 ?g/kg). This treatment resulted in a rapid, but short-term, reduction in detectable peripheral blood resting Tregs (CD4(+)CD45RA(+)Foxp3(+)) and a transient increase in the number of activated Tregs (CD4(+)CD45RA(-)Foxp3(high)), followed by their partial depletion (50-60%). In contrast, all NK cells were deleted immediately and durably after DD administration. This difference was not due to a higher binding or internalization of DD by NK cells compared with Tregs. Coadministration of DD with IL-15, which binds to IL-2R?-?, abrogated DD-induced NK cell deletion in vitro and in vivo, whereas it did not affect Treg elimination. Taken together, these results show that DD exerts a potent cytotoxic effect on NK cells, a phenomenon that might impair its antitumoral properties. However, coadministration of IL-15 with DD could alleviate this problem by selectively protecting potentially oncolytic NK cells, while allowing the depletion of immunosuppressive Tregs in cancer patients.

SUBMITTER: Yamada Y 

PROVIDER: S-EPMC3370077 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Differential effects of denileukin diftitox IL-2 immunotoxin on NK and regulatory T cells in nonhuman primates.

Yamada Yohei Y   Aoyama Akihiro A   Tocco Georges G   Boskovic Svjetlan S   Nadazdin Ognjenka O   Alessandrini Alessandro A   Madsen Joren C JC   Cosimi A Benedict AB   Benichou Gilles G   Kawai Tatsuo T  

Journal of immunology (Baltimore, Md. : 1950) 20120514 12


Denileukin diftitox (DD), a fusion protein comprising IL-2 and diphtheria toxin, was initially expected to enhance antitumor immunity by selectively eliminating regulatory T cells (Tregs) displaying the high-affinity IL-2R (α-β-γ trimers). Although DD was shown to deplete some Tregs in primates, its effects on NK cells (CD16(+)CD8(+)NKG2A(+)CD3(-)), which constitutively express the intermediate-affinity IL-2R (β-γ dimers) and play a critical role in antitumor immunity, are still unknown. To addr  ...[more]

Similar Datasets

| S-EPMC2746471 | biostudies-literature
| S-EPMC3293785 | biostudies-literature
| S-EPMC3523809 | biostudies-literature
| S-EPMC2995354 | biostudies-literature
| S-EPMC6068354 | biostudies-literature
| S-EPMC3266999 | biostudies-literature
| S-EPMC5853937 | biostudies-literature
| S-EPMC4070451 | biostudies-literature
2013-09-04 | E-MTAB-979 | biostudies-arrayexpress
| S-EPMC8201799 | biostudies-literature